SCNI (Scinai Immunotherapeutics) Forward P/E Multiple

Corporate company logo of Scinai (SCNI)

Bioreactor automation and the robotization of antibody filling minimize personnel errors, establishing a foundation for niche protection through nanobody patents and high FDA barriers to entry. The forward P/E valuation of Scinai Immunotherapeutics (SCNI) clearly confirms this trend, with the latest value recorded as 0.00. The development of unique antibodies completes the picture, ensuring long-term leadership in the infection prevention sector.

Projected Price to Earnings: Scinai Immunotherapeutics Ltd. (SCNI) for 02/21/2024 - 11/18/2026

Analytical breakdowns for Scinai Immunotherapeutics

- current price and projected stock value:
Summary company analytics:scinai.com
Product sample of Scinai Immunotherapeutics

Scinai Immunotherapeutics (SCNI) maintains high scientific authority in Israel due to its ethical development of nanoantibodies for the therapy of inflammatory diseases. By analyzing the company's forward P/E ratio, an investor assesses the current asset value relative to expected earnings in one year, which allows for the identification of overvaluation or declining demand by comparing the multiple's dynamics with gold and bond markets.

Competitors of Scinai Immunotherapeutics (SCNI)

Projected Price to Earnings ARGX (Argenx)|BNTX (BioNTech Group) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (Abivax SA)|Market Cap to Projected Earnings admabiologics.com (ADMA)|PTGX - Future Price to Earnings|Immunovant Inc (IMVT) - Projected Price to Earnings|Kiniksa Corp (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols, S.A.|Projected Price to Earnings ADPT|Forward P/E Multiple celldex.com|Future Price to Earnings Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Price to Future Earnings Ratio|Forward P/E Multiple VERA (veratx.com)|Dianthus Pharma (DNTH) - Projected Price to Earnings Ratio|PHVS - Future Price to Earnings|ABCL - Forward P/E Multiple|Tourmaline (TRML) - Future Price to Earnings|Precigen - Future Price to Earnings Multiple|PHAR (Pharming Group NV) - Forward P/E Multiple|Forward P/E Multiple Nektar Therapeutics|Future Price to Earnings Upstream Bio Inc (UPB)|Forward P/E Multiple zenasbio.com (ZBIO)|Future Price to Earnings Immunome Corp IMNM|Forward P/E Multiple Gossamer Bio Inc GOSS|KALV - Future Price to Earnings|Future Price to Earnings Multiple SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - Projected Price to Earnings|Savara Inc. - Future Price to Earnings Multiple|RIGL (Rigel Pharmaceuticals, Inc.) - Forward P/E Multiple|Future Price to Earnings ANAB|Forward P/E Multiple ATXS|ENGN - Projected Price to Earnings Ratio|Forward P/E Multiple RAPT (rapt.com)|Market Cap to Future Earnings Ratio JBIO (Aerovate)|Aclaris Therapeutics, Inc - Forward P/E Multiple|Projected Price to Earnings Ratio Kyverna Therapeutics Inc.|TLSA: Forward P/E Multiple|CABA - Market Cap to Projected Earnings|VTYX (ventyxbio.com) - Forward P/E Multiple|Projected Price to Earnings Ratio Theratechnologies Inc. THTX|Projected Price to Earnings AVTX (avalotx.com)|Projected Price to Earnings Eledon Pharmaceuticals, Inc. ELDN|Future Price to Earnings Agenus, Inc AGEN|Climb Bio Inc - Future Price to Earnings|Zura Bio Limited - Forward P/E Multiple|Market Cap to Projected Earnings aTyr Pharma, Inc. ATYR|ADAG: Forward P/E Multiple|Price to Expected Earnings Ratio IMA (ImageneBio)|Projected Price to Earnings STTK|EQ: Future Price to Earnings Multiple|Future Price to Earnings Connect Pharma (CNTB)|Forward P/E Multiple Immunic Therapeutics (IMUX)|Forward P/E Multiple ATRA (Atara Biotherapeutics)|Future Price to Earnings Multiple IFRX|XFOR (X4 Pharma) - Projected Price to Earnings Ratio|Future Price to Earnings Multiple ACET (adicetbio.com)|CELU: Forward P/E Multiple|inmunebio.com (INMB) - Forward P/E Multiple|BRNS (Barinthus Biotherapeutics PLC) - Forward P/E Multiple|KZR: Future Price to Earnings Multiple|Future Price to Earnings SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics plc) - Future Price to Earnings Multiple|Future Price to Earnings Enlivex Therapeutics Ltd ENLV|QTTB - Projected Price to Earnings|geovax.com - Forward P/E Multiple|Future Price to Earnings Multiple EDSA (Edesa Biotech Inc)|IBIO: Forward P/E Multiple|Carisma Tx (CARM) - Forward P/E Multiple|XTLB (XTL Biopharmaceuticals) - Forward P/E Multiple|BOLT: Future Price to Earnings Multiple|Projected Price to Earnings HCWB (HCW Biologics, Inc.)|Forward P/E Multiple Aptevo (APVO)|Forward P/E Multiple AIM (aimimmuno.com)|Forward P/E Multiple Aditxt Corp ADTX|GRI: Projected Price to Earnings|Future Price to Earnings Multiple XRTX (xortx.com)|Vyome Holdings Inc. (HIND) - Future Price to Earnings|Revelation Bio (REVB) - Forward P/E Multiple|INDP (Indaptus Corp) - Forward P/E Multiple|Projected Price to Earnings Ratio CalciMedica, Inc. CALI|Future Price to Earnings Affimed NV (AFMD)|Forward P/E Multiple Allakos Inc (ALLK)|Future Price to Earnings hookipapharma.com HOOK|Forward P/E Multiple IGM Biosciences, Inc. IGMS|iTeos Pharma - Forward P/E Multiple|OCEA - Forward P/E Multiple|TCBP: Forward P/E Multiple|Third Harmonic Bio - Future Price to Earnings Multiple